16:01 EST DBV Technologies (DBVT) trading halted, news pending
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DBVT:
- DBV Technologies initiated with an Overweight at Cantor Fitzgerald
- DBV Technologies price target raised to $35 from $20 at H.C. Wainwright
- Guggenheim starts DBV Technologies at Buy on peanut allergy market potential
- DBV Technologies initiated with a Buy at Guggenheim
- Optimistic Buy Rating for DBV Technologies Amid Promising VIASKIN Peanut Trial Developments